Insider sale
RAPPORT THERAPEUTICS, INC.
$71.33M
854.71K shares
What this filing means
THIRD ROCK VENTURES V, L.P. plans to sell 854.71K shares of RAPPORT THERAPEUTICS, INC. valued at approximately $71.33M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/27/2026ACC: 0001974078-26-000199
10% Owner
Since Jun 2024
854.71K
Shares to sell
$71.33M
Approx. market value
2.80M
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Original Issuance
cash
2/21/2023
2.80MTotal acquired2.80M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/21/2023 | Original Issuance cash | 2.80M | — |
| Total | 2.80M | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
133.62K
Market value
$5.38M
5/11/2026
—Completed
Units to sell
5.02K
Market value
$202.3K
5/8/2026
—Completed
Units to sell
271.50K
Market value
$47.83M
5/7/2026
—Completed
Units to sell
426K
Market value
$17.18M
4/17/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
18.57K
Market value
$742.9K
5/26/2026
Total
Units
854.71K
Value
$71.33M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/11/2026 | 133.62K | $5.38M | — | Completed |
5/8/2026 | 5.02K | $202.3K | — | Completed |
5/7/2026 | 271.50K | $47.83M | — | Completed |
4/17/2026 | 426K | $17.18M | — | Completed |
| Planned — Approximate Date | ||||
5/26/2026 | 18.57K | $742.9K | Nasdaq | Planned |
| Total | 854.71K | $71.33M | ||